HomeCTNM • NASDAQ
Contineum Therapeutics Inc
Follow
Market news
CBS News
48 minutes ago
Dow Jones plunges more than 1,000 points as stocks react to Trump tariff
shock
3.64%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.05M | 76.18% |
Net income | -14.57M | -87.48% |
Net profit margin | — | — |
Earnings per share | -0.56 | — |
EBITDA | -16.97M | -76.08% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 204.76M | 63.56% |
Total assets | 212.85M | 63.24% |
Total liabilities | 14.78M | 159.22% |
Total equity | 198.07M | — |
Shares outstanding | 25.87M | — |
Price to book | 0.89 | — |
Return on assets | -19.87% | — |
Return on capital | -20.53% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -14.57M | -87.48% |
Cash from operations | -10.20M | 4.69% |
Cash from investing | -9.39M | -203.96% |
Cash from financing | 642.00K | 300.00% |
Net change in cash | -18.95M | -849.77% |
Free cash flow | -5.56M | 20.15% |
Previous close
$6.78
Day range
$6.52 - $6.95
Year range
$5.92 - $22.00
Market cap
174.37M USD
Avg Volume
51.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2009
Website
Employees
41
